United States Biotechnology & Medical Research

Nkarta Inc (NKTX)

Track

Nkarta Inc. experienced two insider trading transactions recently, both involving planned sales by CEO Paul J. Hastings on June 18, 2026. These disposals totaled 9,625.92 USD. The company's stock has declined 24.2% over the past quarter, following a slight miss in its most recent earnings report.
Ticker: NKTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Nkarta Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
84.86
Quantity 73,215 -23.6%
Value US$3,753,716
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
221.16
Quantity 39,873 +45.7%
Value US$1,460,778
1.3
Mahmood Nadir President Officer
Transaction date
Sale
Price
494.48
Quantity 12,292 -12.7%
Value US$3,021,897
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.07
Quantity 26,046 -6.3%
Value US$53,915
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.79
Quantity 1,790 -0.6%
Value US$3,204
3.3
Hager Alicia J. Chief Legal Officer Officer
Transaction date
Sale
Price
2.20
Quantity 9,584 -6.1%
Value US$21,085
3.3
Brandenberger Ralph Chief Technical Officer Officer
Transaction date
Sale
Price
2.20
Quantity 7,447 -5.6%
Value US$16,383
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.20
Quantity 17,378 -5.2%
Value US$38,232
3.1
Shook David See Remarks Officer
Transaction date
Sale
Price
2.20
Quantity 8,638 -4.3%
Value US$19,004
2.5
Levin Alyssa See Remarks Officer
Transaction date
Sale
Price
2.20
Quantity 5,838 -5.4%
Value US$12,844
3.3
Hager Alicia J. Chief Legal Officer Officer
Transaction date
Planned sale
Price
8.00
Quantity 3,396 -3.2%
Value US$27,168
3.3
ALICIA HAGER Officer Officer
Transaction date
Proposed sale
Price
7.02
Quantity 3,396
Value US$23,840
3.1
Shook David Chief Medical Officer Officer
Transaction date
Sale
Price
5.60
Quantity 456 -0.4%
Value US$2,554
2.9
Trager James Chief Scientific Officer Officer
Transaction date
Sale
Price
5.60
Quantity 456 -0.3%
Value US$2,554
3.3
Hager Alicia J. Chief Legal Officer Officer
Transaction date
Sale
Price
5.60
Quantity 727 -0.7%
Value US$4,071
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.60
Quantity 1,770 -0.7%
Value US$9,912
3.3
Brandenberger Ralph Chief Technical Officer Officer
Transaction date
Sale
Price
5.60
Quantity 229 -0.3%
Value US$1,282
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 3,000,000 +42.5%
Value US$30,000,000
3.1
George Simeon Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 451,659 +inf%
Value US$4,516,590
3.1
George Simeon Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 1,548,341 +inf%
Value US$15,483,410
2.8
PAUL J HASTINGS Officer Officer
Transaction date
Proposed sale
Price
12.84
Quantity 60,000
Value US$770,400
3.3
Brandenberger Ralph Chief Technical Officer Officer
Transaction date
Planned sale
Price
12.51
Quantity 8,367 -9.5%
Value US$104,671
2.8
PAUL J HASTINGS Officer Officer
Transaction date
Proposed sale
Price
12.08
Quantity 120,000
Value US$1,449,600
2.9
Trager James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
12.00
Quantity 4,143 -2.7%
Value US$49,716
2.9
JAMES BARNABY TRAGER Officer Officer
Transaction date
Proposed sale
Price
11.11
Quantity 4,143
Value US$46,029
3.3
Brandenberger Ralph Chief Technical Officer Officer
Transaction date
Sale
Price
8.74
Quantity 2,512 -3.0%
Value US$21,955
3.1
Shook David Chief Medical Officer Officer
Transaction date
Sale
Price
8.74
Quantity 3,552 -3.0%
Value US$31,044
2.9
Trager James Chief Scientific Officer Officer
Transaction date
Sale
Price
8.74
Quantity 4,560 -2.9%
Value US$39,854
3.3
Hager Alicia J. Chief Legal Officer Officer
Transaction date
Sale
Price
8.74
Quantity 4,554 -4.0%
Value US$39,802
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Sale
Price
8.74
Quantity 9,697 -2.4%
Value US$84,752
3.1
Shook David Chief Medical Officer Officer
Transaction date
Sale
Price
1.83
Quantity 1,331 -2.2%
Value US$2,436
1.3
Mahmood Nadir See Remarks Officer
Transaction date
Planned sale
Price
4.85
Quantity 526 -0.6%
Value US$2,551
2.9
Trager James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
4.85
Quantity 439 -0.4%
Value US$2,129
3.3
Brandenberger Ralph Chief Technical Officer Officer
Transaction date
Sale
Price
4.85
Quantity 221 -0.8%
Value US$1,072
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
4.85
Quantity 1,704 -0.5%
Value US$8,264
3.3
Hager Alicia J. Chief Legal Officer Officer
Transaction date
Sale
Price
4.85
Quantity 701 -1.2%
Value US$3,400
3.1
Shook David Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.85
Quantity 439 -0.7%
Value US$2,129
3.3
Hager Alicia J. Chief Legal Officer Officer
Transaction date
Sale
Price
5.49
Quantity 1,103 -1.9%
Value US$6,055
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.49
Quantity 3,691 -1.2%
Value US$20,264
2.9
Trager James Chief Scientific Officer Officer
Transaction date
Sale
Price
5.49
Quantity 1,115 -1.1%
Value US$6,121
3.3
Brandenberger Ralph Chief Technical Officer Officer
Transaction date
Sale
Price
5.49
Quantity 491 -1.7%
Value US$2,696
3.1
Shook David Chief Medical Officer Officer
Transaction date
Sale
Price
5.49
Quantity 175 -0.3%
Value US$961
1.3
Mahmood Nadir See Remarks Officer
Transaction date
Planned sale
Price
5.49
Quantity 1,122 -1.3%
Value US$6,160
3.3
Brandenberger Ralph Chief Technical Officer Officer
Transaction date
Planned sale
Price
14.02
Quantity 842 -9.7%
Value US$11,805
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
13.01
Quantity 6,126 -2.2%
Value US$79,717
2.9
Trager James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
17.53
Quantity 5,000 -7.4%
Value US$87,656
3.3
Brandenberger Ralph Chief Technical Officer Officer
Transaction date
Planned sale
Price
17.64
Quantity 11,000 -58.5%
Value US$194,052
1.3
Mahmood Nadir See Remarks Officer
Transaction date
Planned sale
Price
18.03
Quantity 7,500 -14.0%
Value US$135,215
1.3
Mahmood Nadir See Remarks Officer
Transaction date
Planned sale
Price
15.32
Quantity 7,500 -14.0%
Value US$114,900
3.3
Brandenberger Ralph Chief Technical Officer Officer
Transaction date
Planned sale
Price
15.51
Quantity 11,593 -59.8%
Value US$179,783
1.3
Mahmood Nadir See Remarks Officer
Transaction date
Planned sale
Price
13.40
Quantity 7,500 -14.0%
Value US$100,480
3.3
Brandenberger Ralph Chief Technical Officer Officer
Transaction date
Planned sale
Price
13.41
Quantity 3,000 -27.8%
Value US$40,230
3.3
Brandenberger Ralph Sr. VP, Technical Operations Officer
Transaction date
Planned sale
Price
15.00
Quantity 4,140 -43.9%
Value US$62,100
3.1
George Simeon Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 666,666 +inf%
Value US$9,999,990
3.1
George Simeon Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 666,667 +inf%
Value US$10,000,005
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 2,200,000 +39.2%
Value US$33,000,000
3.3
Brandenberger Ralph Sr. VP, Technical Operations Officer
Transaction date
Planned sale
Price
15.64
Quantity 4,140 -100.0%
Value US$64,750
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.53
Quantity 223 -0.1%
Value US$5,916
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.20
Quantity 8,277 -3.6%
Value US$225,134
3.3
Brandenberger Ralph See Remarks Officer
Transaction date
Planned sale
Price
32.08
Quantity 4,140 -100.0%
Value US$132,811
3.5
Rajangam Kanya Chief Medical Officer Officer
Transaction date
Planned sale
Price
37.28
Quantity 10,000 -100.0%
Value US$372,800
1.3
Mahmood Nadir See Remarks Officer
Transaction date
Planned sale
Price
31.71
Quantity 6,500 -19.2%
Value US$206,115
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.89
Quantity 3,807 -1.6%
Value US$102,370
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.39
Quantity 4,693 -2.0%
Value US$123,848
3.3
Brandenberger Ralph See Remarks Officer
Transaction date
Planned sale
Price
24.50
Quantity 4,140 -100.0%
Value US$101,430
1.3
Mahmood Nadir See Remarks Officer
Transaction date
Planned sale
Price
27.16
Quantity 3,000 -9.5%
Value US$81,480
2.9
Trager James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
31.64
Quantity 2,250 -4.7%
Value US$71,190
2.9
Trager James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
31.64
Quantity 1,350 -2.9%
Value US$42,714
1.3
Mahmood Nadir See Remarks Officer
Transaction date
Planned sale
Price
32.70
Quantity 3,500 -10.0%
Value US$114,450
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
32.21
Quantity 3,130 -1.3%
Value US$100,817
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
31.24
Quantity 2,409 -1.0%
Value US$75,257
2.8
HASTINGS PAUL J Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
30.23
Quantity 11,461 -4.5%
Value US$346,466
2.9
Trager James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
40.00
Quantity 2,800 -5.6%
Value US$112,000
2.9
Trager James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
39.46
Quantity 1,566 -3.2%
Value US$61,794
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-18 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
73,215 -23.6%
84.86
US$3,753,716 		73,215 -23.6% 84.86 US$3,753,716
2026-06-22 2026-06-18 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
39,873 +45.7%
221.16
US$1,460,778 		39,873 +45.7% 221.16 US$1,460,778
2026-01-20 2026-01-15 S Sale
1.3
Mahmood Nadir

President

Officer
12,292 -12.7%
494.48
US$3,021,897 		12,292 -12.7% 494.48 US$3,021,897
2026-01-20 2026-01-15 S Sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
26,046 -6.3%
2.07
US$53,915 		26,046 -6.3% 2.07 US$53,915
2025-06-20 2025-06-18 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
1,790 -0.6%
1.79
US$3,204 		1,790 -0.6% 1.79 US$3,204
2025-01-17 2025-01-15 S Sale
3.3
Hager Alicia J.

Chief Legal Officer

Officer
9,584 -6.1%
2.20
US$21,085 		9,584 -6.1% 2.20 US$21,085
2025-01-17 2025-01-15 S Sale
3.3
Brandenberger Ralph

Chief Technical Officer

Officer
7,447 -5.6%
2.20
US$16,383 		7,447 -5.6% 2.20 US$16,383
2025-01-17 2025-01-15 S Sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
17,378 -5.2%
2.20
US$38,232 		17,378 -5.2% 2.20 US$38,232
2025-01-17 2025-01-15 S Sale
3.1
Shook David

See Remarks

Officer
8,638 -4.3%
2.20
US$19,004 		8,638 -4.3% 2.20 US$19,004
2025-01-17 2025-01-15 S Sale
2.5
Levin Alyssa

See Remarks

Officer
5,838 -5.4%
2.20
US$12,844 		5,838 -5.4% 2.20 US$12,844
2024-07-18 2024-07-16 PlS Planned sale
3.3
Hager Alicia J.

Chief Legal Officer

Officer
3,396 -3.2%
8.00
US$27,168 		3,396 -3.2% 8.00 US$27,168
2024-07-16 2024-07-16 PrS Proposed sale
3.3
ALICIA HAGER

Officer

Officer
3,396
7.02
US$23,840 		3,396 7.02 US$23,840
2024-06-20 2024-06-18 S Sale
3.1
Shook David

Chief Medical Officer

Officer
456 -0.4%
5.60
US$2,554 		456 -0.4% 5.60 US$2,554
2024-06-20 2024-06-18 S Sale
2.9
Trager James

Chief Scientific Officer

Officer
456 -0.3%
5.60
US$2,554 		456 -0.3% 5.60 US$2,554
2024-06-20 2024-06-18 S Sale
3.3
Hager Alicia J.

Chief Legal Officer

Officer
727 -0.7%
5.60
US$4,071 		727 -0.7% 5.60 US$4,071
2024-06-20 2024-06-18 S Sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
1,770 -0.7%
5.60
US$9,912 		1,770 -0.7% 5.60 US$9,912
2024-06-20 2024-06-18 S Sale
3.3
Brandenberger Ralph

Chief Technical Officer

Officer
229 -0.3%
5.60
US$1,282 		229 -0.3% 5.60 US$1,282
2024-03-29 2024-03-27 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
3,000,000 +42.5%
10.00
US$30,000,000 		3,000,000 +42.5% 10.00 US$30,000,000
2024-03-28 2024-03-27 B Purchase
3.1
George Simeon
Non-Executive Director
451,659 +inf%
10.00
US$4,516,590 		451,659 +inf% 10.00 US$4,516,590
2024-03-28 2024-03-27 B Purchase
3.1
George Simeon
Non-Executive Director
1,548,341 +inf%
10.00
US$15,483,410 		1,548,341 +inf% 10.00 US$15,483,410
2024-03-04 2024-03-04 PrS Proposed sale
2.8
PAUL J HASTINGS

Officer

Officer
60,000
12.84
US$770,400 		60,000 12.84 US$770,400
2024-03-05 2024-03-01 PlS Planned sale
3.3
Brandenberger Ralph

Chief Technical Officer

Officer
8,367 -9.5%
12.51
US$104,671 		8,367 -9.5% 12.51 US$104,671
2024-03-01 2024-03-01 PrS Proposed sale
3.3
RALPH ERIK BRANDENBERGER

Officer

Officer
8,367
12.08
US$101,073 		8,367 12.08 US$101,073
2024-03-01 2024-03-01 PrS Proposed sale
2.8
PAUL J HASTINGS

Officer

Officer
120,000
12.08
US$1,449,600 		120,000 12.08 US$1,449,600
2024-02-14 2024-02-12 PlS Planned sale
2.9
Trager James

Chief Scientific Officer

Officer
4,143 -2.7%
12.00
US$49,716 		4,143 -2.7% 12.00 US$49,716
2024-02-12 2024-02-12 PrS Proposed sale
2.9
JAMES BARNABY TRAGER

Officer

Officer
4,143
11.11
US$46,029 		4,143 11.11 US$46,029
2024-01-18 2024-01-16 S Sale
3.3
Brandenberger Ralph

Chief Technical Officer

Officer
2,512 -3.0%
8.74
US$21,955 		2,512 -3.0% 8.74 US$21,955
2024-01-18 2024-01-16 S Sale
3.1
Shook David

Chief Medical Officer

Officer
3,552 -3.0%
8.74
US$31,044 		3,552 -3.0% 8.74 US$31,044
2024-01-18 2024-01-16 S Sale
2.9
Trager James

Chief Scientific Officer

Officer
4,560 -2.9%
8.74
US$39,854 		4,560 -2.9% 8.74 US$39,854
2024-01-18 2024-01-16 S Sale
3.3
Hager Alicia J.

Chief Legal Officer

Officer
4,554 -4.0%
8.74
US$39,802 		4,554 -4.0% 8.74 US$39,802
2024-01-18 2024-01-16 S Sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
9,697 -2.4%
8.74
US$84,752 		9,697 -2.4% 8.74 US$84,752
2023-08-23 2023-08-21 S Sale
3.1
Shook David

Chief Medical Officer

Officer
1,331 -2.2%
1.83
US$2,436 		1,331 -2.2% 1.83 US$2,436
2023-06-22 2023-06-20 PlS Planned sale
1.3
Mahmood Nadir

See Remarks

Officer
526 -0.6%
4.85
US$2,551 		526 -0.6% 4.85 US$2,551
2023-06-22 2023-06-20 PlS Planned sale
2.9
Trager James

Chief Scientific Officer

Officer
439 -0.4%
4.85
US$2,129 		439 -0.4% 4.85 US$2,129
2023-06-22 2023-06-20 S Sale
3.3
Brandenberger Ralph

Chief Technical Officer

Officer
221 -0.8%
4.85
US$1,072 		221 -0.8% 4.85 US$1,072
2023-06-22 2023-06-20 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
1,704 -0.5%
4.85
US$8,264 		1,704 -0.5% 4.85 US$8,264
2023-06-22 2023-06-20 S Sale
3.3
Hager Alicia J.

Chief Legal Officer

Officer
701 -1.2%
4.85
US$3,400 		701 -1.2% 4.85 US$3,400
2023-06-22 2023-06-20 PlS Planned sale
3.1
Shook David

Chief Medical Officer

Officer
439 -0.7%
4.85
US$2,129 		439 -0.7% 4.85 US$2,129
2023-01-18 2023-01-17 S Sale
3.3
Hager Alicia J.

Chief Legal Officer

Officer
1,103 -1.9%
5.49
US$6,055 		1,103 -1.9% 5.49 US$6,055
2023-01-18 2023-01-17 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
3,691 -1.2%
5.49
US$20,264 		3,691 -1.2% 5.49 US$20,264
2023-01-18 2023-01-17 S Sale
2.9
Trager James

Chief Scientific Officer

Officer
1,115 -1.1%
5.49
US$6,121 		1,115 -1.1% 5.49 US$6,121
2023-01-18 2023-01-17 S Sale
3.3
Brandenberger Ralph

Chief Technical Officer

Officer
491 -1.7%
5.49
US$2,696 		491 -1.7% 5.49 US$2,696
2023-01-18 2023-01-17 S Sale
3.1
Shook David

Chief Medical Officer

Officer
175 -0.3%
5.49
US$961 		175 -0.3% 5.49 US$961
2023-01-18 2023-01-17 PlS Planned sale
1.3
Mahmood Nadir

See Remarks

Officer
1,122 -1.3%
5.49
US$6,160 		1,122 -1.3% 5.49 US$6,160
2022-10-07 2022-10-06 PlS Planned sale
3.3
Brandenberger Ralph

Chief Technical Officer

Officer
842 -9.7%
14.02
US$11,805 		842 -9.7% 14.02 US$11,805
2022-09-22 2022-09-21 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
6,126 -2.2%
13.01
US$79,717 		6,126 -2.2% 13.01 US$79,717
2022-08-17 2022-08-15 PlS Planned sale
2.9
Trager James

Chief Scientific Officer

Officer
5,000 -7.4%
17.53
US$87,656 		5,000 -7.4% 17.53 US$87,656
2022-08-17 2022-08-15 PlS Planned sale
3.3
Brandenberger Ralph

Chief Technical Officer

Officer
11,000 -58.5%
17.64
US$194,052 		11,000 -58.5% 17.64 US$194,052
2022-08-17 2022-08-15 PlS Planned sale
1.3
Mahmood Nadir

See Remarks

Officer
7,500 -14.0%
18.03
US$135,215 		7,500 -14.0% 18.03 US$135,215
2022-08-10 2022-08-08 PlS Planned sale
1.3
Mahmood Nadir

See Remarks

Officer
7,500 -14.0%
15.32
US$114,900 		7,500 -14.0% 15.32 US$114,900
2022-08-10 2022-08-08 PlS Planned sale
3.3
Brandenberger Ralph

Chief Technical Officer

Officer
11,593 -59.8%
15.51
US$179,783 		11,593 -59.8% 15.51 US$179,783
2022-07-26 2022-07-25 PlS Planned sale
1.3
Mahmood Nadir

See Remarks

Officer
7,500 -14.0%
13.40
US$100,480 		7,500 -14.0% 13.40 US$100,480
2022-07-26 2022-07-25 PlS Planned sale
3.3
Brandenberger Ralph

Chief Technical Officer

Officer
3,000 -27.8%
13.41
US$40,230 		3,000 -27.8% 13.41 US$40,230
2022-06-07 2022-06-03 PlS Planned sale
3.3
Brandenberger Ralph

Sr. VP, Technical Operations

Officer
4,140 -43.9%
15.00
US$62,100 		4,140 -43.9% 15.00 US$62,100
2022-04-29 2022-04-28 B Purchase
3.1
George Simeon
Non-Executive Director
666,666 +inf%
15.00
US$9,999,990 		666,666 +inf% 15.00 US$9,999,990
2022-04-29 2022-04-28 B Purchase
3.1
George Simeon
Non-Executive Director
666,667 +inf%
15.00
US$10,000,005 		666,667 +inf% 15.00 US$10,000,005
2022-04-28 2022-04-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
2,200,000 +39.2%
15.00
US$33,000,000 		2,200,000 +39.2% 15.00 US$33,000,000
2021-12-03 2021-12-01 PlS Planned sale
3.3
Brandenberger Ralph

Sr. VP, Technical Operations

Officer
4,140 -100.0%
15.64
US$64,750 		4,140 -100.0% 15.64 US$64,750
2021-10-01 2021-09-29 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
223 -0.1%
26.53
US$5,916 		223 -0.1% 26.53 US$5,916
2021-10-01 2021-09-29 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
8,277 -3.6%
27.20
US$225,134 		8,277 -3.6% 27.20 US$225,134
2021-09-02 2021-09-01 PlS Planned sale
3.3
Brandenberger Ralph

See Remarks

Officer
4,140 -100.0%
32.08
US$132,811 		4,140 -100.0% 32.08 US$132,811
2021-08-09 2021-08-05 PlS Planned sale
3.5
Rajangam Kanya

Chief Medical Officer

Officer
10,000 -100.0%
37.28
US$372,800 		10,000 -100.0% 37.28 US$372,800
2021-07-06 2021-07-01 PlS Planned sale
1.3
Mahmood Nadir

See Remarks

Officer
6,500 -19.2%
31.71
US$206,115 		6,500 -19.2% 31.71 US$206,115
2021-06-23 2021-06-21 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
3,807 -1.6%
26.89
US$102,370 		3,807 -1.6% 26.89 US$102,370
2021-06-23 2021-06-21 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
4,693 -2.0%
26.39
US$123,848 		4,693 -2.0% 26.39 US$123,848
2021-06-04 2021-06-02 PlS Planned sale
3.3
Brandenberger Ralph

See Remarks

Officer
4,140 -100.0%
24.50
US$101,430 		4,140 -100.0% 24.50 US$101,430
2021-05-12 2021-05-10 PlS Planned sale
1.3
Mahmood Nadir

See Remarks

Officer
3,000 -9.5%
27.16
US$81,480 		3,000 -9.5% 27.16 US$81,480
2021-05-05 2021-05-03 PlS Planned sale
2.9
Trager James

Chief Scientific Officer

Officer
2,250 -4.7%
31.64
US$71,190 		2,250 -4.7% 31.64 US$71,190
2021-05-05 2021-05-03 PlS Planned sale
2.9
Trager James

Chief Scientific Officer

Officer
1,350 -2.9%
31.64
US$42,714 		1,350 -2.9% 31.64 US$42,714
2021-04-02 2021-04-01 PlS Planned sale
1.3
Mahmood Nadir

See Remarks

Officer
3,500 -10.0%
32.70
US$114,450 		3,500 -10.0% 32.70 US$114,450
2021-04-01 2021-03-30 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
3,130 -1.3%
32.21
US$100,817 		3,130 -1.3% 32.21 US$100,817
2021-04-01 2021-03-30 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
2,409 -1.0%
31.24
US$75,257 		2,409 -1.0% 31.24 US$75,257
2021-04-01 2021-03-30 PlS Planned sale
2.8
HASTINGS PAUL J

Chief Executive Officer

Executive Director
11,461 -4.5%
30.23
US$346,466 		11,461 -4.5% 30.23 US$346,466
2021-02-03 2021-02-02 PlS Planned sale
2.9
Trager James

Chief Scientific Officer

Officer
2,800 -5.6%
40.00
US$112,000 		2,800 -5.6% 40.00 US$112,000
2021-02-03 2021-02-01 PlS Planned sale
2.9
Trager James

Chief Scientific Officer

Officer
1,566 -3.2%
39.46
US$61,794 		1,566 -3.2% 39.46 US$61,794
Explore more

More insider trading research around Nkarta Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America